drugset / Trial / NCT00176618
The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon
RandomizedSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to determine the effectiveness of curcumin in reducing the number of aberrant crypt foci (ACF) in the colon.
Timeline
- Start
- 2004-04
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcumin | Small molecule | 250 mg | Oral |
| Subject | Sulindac | Small molecule | 150 mg | Oral |
Indications
No indication recorded.